Posts
London, United Kingdom. The University of Cambridge has received in 2010 £100.000 from the charity fund of the Freemasons of the United Grand Lodge of England. On November 14, 2011 it was announced a major success in the research of a new drug (alemtuzumab). The drug is designed to help people suffering from multiple sclerosis.
